242 related articles for article (PubMed ID: 35352776)
1. Natural compounds based chemotherapeutic against Chagas disease and leishmaniasis: mitochondrion as a strategic target.
Lazarin-Bidóia D; Garcia FP; Ueda-Nakamura T; Silva SO; Nakamura CV
Mem Inst Oswaldo Cruz; 2022; 117():e220396. PubMed ID: 35352776
[TBL] [Abstract][Full Text] [Related]
2. Exploring microalgal and cyanobacterial metabolites with antiprotozoal activity against Leishmania and Trypanosoma parasites.
Matos ÂP; Saldanha-Corrêa FMP; Gomes RDS; Hurtado GR
Acta Trop; 2024 Mar; 251():107116. PubMed ID: 38159713
[TBL] [Abstract][Full Text] [Related]
3. Targeting calcium homeostasis as the therapy of Chagas' disease and leishmaniasis - a review.
Benaim B; Garcia CR
Trop Biomed; 2011 Dec; 28(3):471-81. PubMed ID: 22433874
[TBL] [Abstract][Full Text] [Related]
4. The Role of Nitro (NO
Kamdem BP; Elizabeth FI
Curr Drug Targets; 2021; 22(4):379-398. PubMed ID: 33371845
[TBL] [Abstract][Full Text] [Related]
5. High-throughput screening platform for natural product-based drug discovery against 3 neglected tropical diseases: human African trypanosomiasis, leishmaniasis, and Chagas disease.
Annang F; Pérez-Moreno G; García-Hernández R; Cordon-Obras C; Martín J; Tormo JR; Rodríguez L; de Pedro N; Gómez-Pérez V; Valente M; Reyes F; Genilloud O; Vicente F; Castanys S; Ruiz-Pérez LM; Navarro M; Gamarro F; González-Pacanowska D
J Biomol Screen; 2015 Jan; 20(1):82-91. PubMed ID: 25332350
[TBL] [Abstract][Full Text] [Related]
6. Bisphosphonate-Based Molecules as Potential New Antiparasitic Drugs.
Branco Santos JC; de Melo JA; Maheshwari S; de Medeiros WMTQ; de Freitas Oliveira JW; Moreno CJ; Mario Amzel L; Gabelli SB; Sousa Silva M
Molecules; 2020 Jun; 25(11):. PubMed ID: 32503272
[TBL] [Abstract][Full Text] [Related]
7. Antioxidant defence system as a rational target for Chagas disease and Leishmaniasis chemotherapy.
Santi AMM; Murta SMF
Mem Inst Oswaldo Cruz; 2022; 117():e210401. PubMed ID: 35239945
[TBL] [Abstract][Full Text] [Related]
8. Germacranolide-type sesquiterpene lactones from Smallanthus sonchifolius with promising activity against Leishmania mexicana and Trypanosoma cruzi.
Ulloa JL; Spina R; Casasco A; Petray PB; Martino V; Sosa MA; Frank FM; Muschietti LV
Parasit Vectors; 2017 Nov; 10(1):567. PubMed ID: 29132413
[TBL] [Abstract][Full Text] [Related]
9. Cysteine synthase: multiple structures of a key enzyme in cysteine synthesis and a potential drug target for Chagas disease and leishmaniasis.
Sowerby K; Freitag-Pohl S; Murillo AM; Silber AM; Pohl E
Acta Crystallogr D Struct Biol; 2023 Jun; 79(Pt 6):518-530. PubMed ID: 37204818
[TBL] [Abstract][Full Text] [Related]
10. N
Lin C; Jaén Batista DDG; Mazzeti AL; Donola Girão R; de Oliveira GM; Karalic I; Hulpia F; Soeiro MNC; Maes L; Caljon G; Van Calenbergh S
Eur J Med Chem; 2022 Mar; 231():114165. PubMed ID: 35144125
[TBL] [Abstract][Full Text] [Related]
11. Strategies for overcoming tropical disease by ruthenium complexes with purine analog: Application against Leishmania spp. and Trypanosoma cruzi.
Fandzloch M; Arriaga JMM; Sánchez-Moreno M; Wojtczak A; Jezierska J; Sitkowski J; Wiśniewska J; Salas JM; Łakomska I
J Inorg Biochem; 2017 Nov; 176():144-155. PubMed ID: 28910663
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and characterization of a pyridine-2-thiol N-oxide gold(I) complex with potent antiproliferative effect against Trypanosoma cruzi and Leishmania sp. insight into its mechanism of action.
Vieites M; Smircich P; Guggeri L; Marchán E; Gómez-Barrio A; Navarro M; Garat B; Gambino D
J Inorg Biochem; 2009 Oct; 103(10):1300-6. PubMed ID: 19361864
[TBL] [Abstract][Full Text] [Related]
13. In vitro evaluation of arylsubstituted imidazoles derivatives as antiprotozoal agents and docking studies on sterol 14α-demethylase (CYP51) from Trypanosoma cruzi, Leishmania infantum, and Trypanosoma brucei.
Rojas Vargas JA; López AG; Pérez Y; Cos P; Froeyen M
Parasitol Res; 2019 May; 118(5):1533-1548. PubMed ID: 30903349
[TBL] [Abstract][Full Text] [Related]
14. Challenges in drug discovery targeting TriTryp diseases with an emphasis on leishmaniasis.
Alcântara LM; Ferreira TCS; Gadelha FR; Miguel DC
Int J Parasitol Drugs Drug Resist; 2018 Dec; 8(3):430-439. PubMed ID: 30293058
[TBL] [Abstract][Full Text] [Related]
15. A Nature-Inspired Design Yields a New Class of Steroids Against Trypanosomatids.
Aguilera E; Perdomo C; Espindola A; Corvo I; Faral-Tello P; Robello C; Serna E; Benítez F; Riveros R; Torres S; Vera de Bilbao NI; Yaluff G; Alvarez G
Molecules; 2019 Oct; 24(20):. PubMed ID: 31652542
[TBL] [Abstract][Full Text] [Related]
16. Repositioning of leishmanicidal [1,2,3]Triazolo[1,5-a]pyridinium salts for Chagas disease treatment: Trypanosoma cruzi cell death involving mitochondrial membrane depolarisation and Fe-SOD inhibition.
Martín-Escolano R; Martín-Escolano J; Ballesteros-Garrido R; Cirauqui N; Abarca B; Rosales MJ; Sánchez-Moreno M; Ballesteros R; Marín C
Parasitol Res; 2020 Sep; 119(9):2943-2954. PubMed ID: 32607710
[TBL] [Abstract][Full Text] [Related]
17. Lanthanide complexes containing 5-methyl-1,2,4-triazolo[1,5-a] pyrimidin-7(4H)-one and their therapeutic potential to fight leishmaniasis and Chagas disease.
Caballero AB; Rodríguez-Diéguez A; Salas JM; Sánchez-Moreno M; Marín C; Ramírez-Macías I; Santamaría-Díaz N; Gutiérrez-Sánchez R
J Inorg Biochem; 2014 Sep; 138():39-46. PubMed ID: 24861807
[TBL] [Abstract][Full Text] [Related]
18. Taiwaniaquinoid and abietane quinone derivatives with trypanocidal activity against T. cruzi and Leishmania spp.
Ramírez-Macías I; Marín C; Es-Samti H; Fernández A; Guardia JJ; Zentar H; Agil A; Chahboun R; Alvarez-Manzaneda E; Sánchez-Moreno M
Parasitol Int; 2012 Sep; 61(3):405-13. PubMed ID: 22366342
[TBL] [Abstract][Full Text] [Related]
19. The kinetoplastid chemotherapy revisited: current drugs, recent advances and future perspectives.
Castillo E; Dea-Ayuela MA; Bolás-Fernández F; Rangel M; González-Rosende ME
Curr Med Chem; 2010; 17(33):4027-51. PubMed ID: 20939823
[TBL] [Abstract][Full Text] [Related]
20. Effects of Structurally Different HDAC Inhibitors against
Di Bello E; Noce B; Fioravanti R; Zwergel C; Valente S; Rotili D; Fianco G; Trisciuoglio D; Mourão MM; Sales P; Lamotte S; Prina E; Späth GF; Häberli C; Keiser J; Mai A
ACS Infect Dis; 2022 Jul; 8(7):1356-1366. PubMed ID: 35732073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]